Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Retinoblastoma × racotumomab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Other solid neoplasm 1 Genitourinary 1 CNS 1

Conditions

Small Cell Lung Carcinoma 2 Neuroblastoma 2 Wilms Tumor 1 Sarcoma, Ewing 1 Retinoblastoma 1 Glioma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

racotumomab 1 LY2940680 1 Biological Factors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01598454 2015-07-29

Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides

Laboratorio Elea Phoenix S.A.

Phase 1 Completed

CNSGenitourinaryOther solid neoplasmSarcoma

Glioma, Wilms Tumor, Neuroblastoma, Retinoblastoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡